Xilong Scientific Co., Ltd. / Fundamentals
Income statement
- Net revenue
€868.61M - Cost of goods sold
€806.28M - Gross profit
€62.34M - SG&A expenses
-€1.87M - R&D expenses
€12.23M - EBITDA
-€308.15K - D&A
€0.00 - EBIT
€13.60M - Interest expenses
€4.94M - EBT
-€5.04M - Tax expenses
€1.48M - Net income
-€6.69M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€9.41M - Changes in working capital
€0.00 - Operating cash flow
€11.97M - Capex
€5.09M - Other investing cash flow
-€3.10M - Net investing cash flow
-€8.51M - Total cash dividends paid
-€9.15M - Issuance of common stock
€0.00 - Debt repayment
-€12.78M - Other financing cash flow
-€15.18M - Net financing cash flow
-€37.11M - Foreign exchange effects
-€387.74K - Net change in cash
€7.86M - Cash at end of period
€28.46M - Free cash flow
€17.06M
Balance sheet
- Cash and cash equivalents
€87.86M - Cash and short-term investments
€88.00M - Total receivables
€229.09M - Inventory
€73.21M - Other current assets
€36.08M - Total current assets
€426.38M - Property, plant & equipment
€98.75M - Goodwill
€0.00 - Intangible assets
€20.74M - Long-term investments
€0.00 - Other non-current assets
€48.35M - Total non-current assets
€169.61M - Total assets
€595.99M - Accounts payable
€135.17M - Short-term debt
€82.01M - Other current liabilities
€49.01M - Total current liabilities
€271.70M - Long-term debt
€31.37M - Deferred tax liabilities
€321.56K - Other non-current liabilities
€22.61M - Total non-current liabilities
€59.08M - Total liabilities
€330.78M - Common stock
€69.63M - Retained earnings
€94.23M - Other equity
€0.00 - Total equity
€265.21M - Total liabilities and shareholders' equity
€595.99M
Company information
- Market capitalization
€687.25M - Employees
1.2K - Enterprise Value
€6.01B
Company ratios
- Gross margin
-
7.2% Worse than peer group: 21.4% - EBITDA margin
-
-0.0% Worse than peer group: 10.9% - EBIT margin
-
1.6% Worse than peer group: 7.3% - EBT margin
-
-0.6% Worse than peer group: 7.0% - Net margin
-
-0.8% Worse than peer group: 5.3% - ROE
-
-2.5% Worse than peer group: 6.9% - ROA
-
-1.1% Worse than peer group: 4.2% - Asset turnover
-
145.7% Much better than peer group: 62.4% - FCF margin
-
0.8% Even with peer group: -3.7% - FCF yield
1.0% - Efficiency ratio
100.0% - Net sales per employee
-
€749.45K - Net income per employee
-
-€5.77K